Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 90 member A17 (FAM90A17) is annotated as a protein-coding gene in humans, but its precise function is unknown. Some databases list it as a putative pseudogene. There is strong evolutionary conservation and proteomics evidence for expression, but no experimental demonstration of protein function, biological pathway involvement, or disease implication. FAM90A17 does not belong to any classical receptor, enzyme, transporter, ion channel, or transcription factor family. It is not considered a therapeutic target, nor are there documented drugs, mechanisms, or biomarkers associated with FAM90A17. Current biomedical resources do not link it to any disease or safety concern. If you are seeking a validated receptor or enzyme, this target is not considered to fit that definition as of current knowledge, and it is likely a mis-annotation or placeholder in target lists.
None known (no mechanism of action for drugs documented to target FAM90A17)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 90 member A17 (FAM90A17).